scholarly journals Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy

2019 ◽  
Vol 137 ◽  
pp. 71-76 ◽  
Author(s):  
Alan McWilliam ◽  
Eliana Vasquez Osorio ◽  
Corinne Faivre-Finn ◽  
Marcel van Herk
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Survival ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals P2.16-08 Influence of Tumour Location and Histological Sub-Type of Non-Small Cell Lung Cancer on Patient Survival

2018 ◽  
Vol 13 (10) ◽  
pp. S833-S834 ◽  
Author(s):  
A. McWilliam ◽  
A. Davey ◽  
E. Vasquez Osorio ◽  
M. Aznar ◽  
C. Faivre-Finn ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Survival ◽  
Small Cell ◽  
Small Cell Lung ◽  
Tumour Location

scholarly journals Loss of Heterozygosity of Chromosome 3p21 Is Associated with Mutant TP53 and Better Patient Survival in Non–Small-Cell Lung Cancer

2004 ◽  
Vol 64 (23) ◽  
pp. 8702-8707 ◽  
Author(s):  
Carmen J. Marsit ◽  
Masayuki Hasegawa ◽  
Tomoko Hirao ◽  
Duk-Hwan Kim ◽  
Kenneth Aldape ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Loss Of Heterozygosity ◽  
Cell Lung Cancer ◽  
Patient Survival ◽  
Small Cell ◽  
Small Cell Lung ◽  
Chromosome 3P21

Palliative care and psychosocial care in metastatic non-small cell lung cancer: factors affecting utilisation of services and impact on patient survival

2018 ◽  
Vol 27 (3) ◽  
pp. 911-919 ◽  
Author(s):  
Kirsten J. Duggan ◽  
Jennifer Wiltshire ◽  
Rebecca Strutt ◽  
Miriam M. Boxer ◽  
Angela Berthelsen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Palliative Care ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Survival ◽  
Psychosocial Care ◽  
Small Cell ◽  
Small Cell Lung ◽  
Factors Affecting

scholarly journals p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival

1995 ◽  
Vol 6 ◽  
pp. S9-S13 ◽  
Author(s):  
T. Mitsudomi ◽  
T. Oyama ◽  
K. Nishida ◽  
A. Ogami ◽  
T. Osaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Survival ◽  
Gene Mutations ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals The type III TGF beta receptor is differentially expressed in non-small cell lung cancer and associates with patient survival.

2020 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Transforming Growth Factor ◽  
Patient Survival ◽  
The United States ◽  
Small Cell ◽  
Differentially Expressed ◽  
Small Cell Lung ◽  
Type Iii

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the United States (1). We mined published microarray data (2, 3, 4) to identify differentially expressed genes in NSCLC. We found that the gene encoding the type III transforming growth factor (TGF)-β receptor, TGFBR3, was among the genes whose expression was most quantitatively different in tumors from patients with NSCLC as compared to the lung. TGFBR3 expression was significantly decreased in NSCLC tumors as compared to the lung, and lower expression of TGFBR3 in patient tumors was significantly associated with worse overall survival. We previously reported differential and decreased expression of LTBP4 (5) which associated with patient survival in NSCLC. TGFBR3, and the TGF-β signaling pathway may be important for initiation or progression of non-small cell lung cancer in humans.

scholarly journals The roundabout guidance receptor 4, ROBO4, is differentially expressed in non-small cell lung cancer and associates with patient survival.

2020 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Microarray Data ◽  
Patient Survival ◽  
The United States ◽  
Small Cell ◽  
Differentially Expressed ◽  
Small Cell Lung ◽  
Lower Expression

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the United States (1). We mined published microarray data (2, 3, 4) to identify differentially expressed genes in NSCLC. We found that ROBO4 was among the genes whose expression was most quantitatively different in tumors from patients with NSCLC as compared to the lung. ROBO4 expression was significantly decreased in NSCLC tumors as compared to the lung, and lower expression of ROBO4 in patient tumors was significantly associated with worse overall survival. ROBO4 may be important for initiation or progression of non-small cell lung cancer in humans.

scholarly journals YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer

2021 ◽  
Vol 10 (1) ◽  
pp. 1962656
Author(s):  
Kazuo Tsuchiya ◽  
Katsuhiro Yoshimura ◽  
Yusuke Inoue ◽  
Yuji Iwashita ◽  
Hidetaka Yamada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Survival ◽  
Small Cell ◽  
Small Cell Lung ◽  
Immune Microenvironment ◽  
Tumor Immune Microenvironment

scholarly journals ADH1B is differentially expressed in non-small cell lung cancer and associates with patient survival.

2020 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Microarray Data ◽  
Patient Survival ◽  
The United States ◽  
Small Cell ◽  
Differentially Expressed ◽  
Small Cell Lung ◽  
Lower Expression

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the United States (1). We mined published microarray data (2, 3, 4) to identify differentially expressed genes in NSCLC. We found that ADH1B was among the genes whose expression was most quantitatively different in tumors from patients with NSCLC as compared to the lung. ADH1B expression was significantly decreased in NSCLC tumors as compared to the lung, and lower expression of ADH1B in patient tumors was significantly associated with worse overall survival. ADH1B may be important for initiation or progression of non-small cell lung cancer in humans.

Sign in / Sign up

Export Citation Format

Share Document